Aurora Spine Corp. ASG
TSXV · Canada · Health Technology
CAD 0.14000.00 (0.00%)
Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · CAD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Carlsbad, California--(Newsfile Corp. - September 29, 2026) - Aurora Spine Corporation (TSXV: ASG) ("Aurora Spine" or the "Company") announced today that an insider of the Company has agreed to increase the principal amount available under an existing loan with the Company (the "Loan") by US$200,000. As a result of this increase, the total principal amount owing by the Company to the insider is US$2.4 million (the "Principal Amount"). The Company intends to use the Loan proceeds for general...
Aurora Spine (ASG.V) reported a second-quarter net loss of $0.01 per share, compared with breakeven
- Company to host conference call Today, August 27th at 11am ET/8am PT -NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICESCarlsbad, California--(Newsfile Corp. - August 27, 2026) - Aurora Spine Corporation (TSXV: ASG) (OTCQB: ASAPF) ("Aurora Spine" or the "Company"), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its financial results for the second quarter of fiscal year 2026 ended June 30, 2026. All figures are in...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.